Fludarabine phosphate 25 mg/ml Concentrate for Solution for Injection or Infusion clinical trials
5 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2, Multicenter Study of Autologous Tumor Infiltrating Lymphocytes (LN-144/LN-145/LN-145-S1) in Patients with Solid Tumors
This study looks at a new treatment for solid tumours, which are common types of cancer. It uses a patient's own immune cells, called TILs, to fight the cancer. Researchers want to see how well these cells work at shrinking tumours and keeping the cancer away.
For: NeoplasmSpain · Germany · Greece - AuthorisedTherapeutic confirmatory (Phase III)
The INFLUENCE Trial: Improving EveNt Free Survival by Optimizing FLUdarabine Exposure during LymphodepletioN for CAR T CEll Therapy: a randomized, multi-center study of children and young adults with B-cell acute lymphoblastic leukemia
This study looks at how a medicine called fludarabine, used with CAR T-cell therapy, affects children and young adults with a type of blood cancer called B-cell Acute Lymphoblastic Leukemia. It compares different ways of giving fludarabine to see which works best.
For: B-cell Acute Lymphoblastic LeukemiaSpain · Germany · Netherlands - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Single-Arm, Open-Label, Phase 1/2 Study Evaluating the Safety, Efficacy, and Cellular Kinetics/Pharmacodynamics of ALLO-501A, an Anti-CD19 Allogeneic CAR T Cell Therapy, and ALLO-647, an Anti-CD52 Monoclonal Antibody, in Subjects with Relapsed/Refractory Large B Cell Lymphoma (LBCL).
This study is testing a new cell therapy called ALLO-501A, along with another drug called ALLO-647, for adults with a type of blood cancer called Large B-Cell Lymphoma, where previous treatments haven't worked. It aims to see how safe and effective these new treatments are.
For: Large B-Cell Lymphoma (LBCL)Italy · Spain - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Randomized, Open-Label, Phase 2 Study Evaluating Lymphodepletion With Fludarabine, Cyclophosphamide, And ALLO-647, Vs. Fludarabine And Cyclophosphamide Alone, In Subjects With Relapsed/Refractory Large B-Cell Lymphoma (LBCL) Receiving ALLO-501A Allogeneic CAR T Cell Therapy
This study is testing a new way to prepare people with a type of lymphoma (LBCL) for a special cell therapy called ALLO-501A. It compares two methods of preparing the body to see which works best and is safest.
For: Large B-Cell Lymphoma (LBCL)Belgium · Germany · Austria - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2 Multicenter Study Evaluating the Efficacy of KTE-X19 in Subjects with Relapsed/Refractory Mantle Cell Lymphoma (ZUMA-2)
This study is looking at a new treatment called KTE-X19 for a type of cancer called Mantle Cell Lymphoma. It's for people whose cancer has come back or hasn't responded to previous treatments. Researchers want to see how well the new treatment shrinks the cancer.
For: Relapsed/Refractory Mantle Cell LymphomaFrance · Spain · Germany